HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annamaria Szabolcs Selected Research

Ovarian Epithelial Carcinoma

1/2022Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annamaria Szabolcs Research Topics

Disease

9Neoplasms (Cancer)
01/2023 - 01/2011
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2011
4Adenocarcinoma
01/2022 - 01/2013
3Virus Diseases (Viral Diseases)
01/2022 - 08/2020
3COVID-19
01/2021 - 08/2020
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2021
2Breast Neoplasms (Breast Cancer)
12/2020 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2020
2Pancreatitis
01/2006 - 02/2005
2Body Weight (Weight, Body)
01/2006 - 02/2005
1Ovarian Epithelial Carcinoma
01/2022
1Brain Neoplasms (Brain Tumor)
12/2020
1Hypoxia (Hypoxemia)
12/2020
1Circulating Neoplastic Cells
01/2020
1Pathologic Processes
10/2010
1Chronic Pancreatitis
03/2007
1Acute Necrotizing Pancreatitis
01/2006

Drug/Important Bio-Agent (IBA)

8RNA (Ribonucleic Acid)IBA
01/2022 - 12/2019
4Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2020
3InterferonsIBA
01/2022 - 08/2020
2Immune Checkpoint InhibitorsIBA
01/2023 - 11/2021
2Cetuximab (Erbitux)FDA Link
01/2013 - 01/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 02/2005
2Peroxidase (Myeloperoxidase)IBA
01/2006 - 02/2005
2AmylasesFDA Link
01/2006 - 02/2005
1NucleosidesIBA
01/2022
1Nucleic AcidsIBA
01/2022
1Reverse Transcriptase InhibitorsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1DNA Transposable Elements (Element, IS)IBA
01/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1ElementsIBA
01/2022
1Viral ProteinsIBA
01/2021
1Coloring Agents (Dyes)IBA
01/2021
1Viral RNAIBA
01/2021
1Small Interfering RNA (siRNA)IBA
12/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2020
1folfirinoxIBA
12/2019
1GoldIBA
01/2013
1GemcitabineFDA Link
01/2013
1Nucleoside Transport Proteins (Nucleoside Transporter)IBA
01/2013
14-nitrobenzylthioinosineIBA
01/2013
1CaspasesIBA
03/2011
1Cisplatin (Platino)FDA LinkGeneric
03/2011
1Monoclonal AntibodiesIBA
01/2011
1NanoconjugatesIBA
01/2011
1ErbB Receptors (EGF Receptor)IBA
01/2011
1Transforming Growth Factor beta (TGF-beta)IBA
10/2010
1CytokinesIBA
03/2007
1Interleukin-8 (Interleukin 8)IBA
03/2007
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2007
1Interleukin-6 (Interleukin 6)IBA
01/2006
1AntioxidantsIBA
01/2006
1Superoxide Dismutase-1IBA
01/2006
1Arginine (L-Arginine)FDA Link
01/2006
1CatalaseIBA
01/2006
1EnzymesIBA
01/2006
1MelatoninIBA
01/2006
1Transcription Factors (Transcription Factor)IBA
02/2005
1Peptides (Polypeptides)IBA
02/2005
1NF-kappa B (NF-kB)IBA
02/2005
1Glutathione (Reduced Glutathione)IBA
02/2005
1Cholecystokinin (Pancreozymin)IBA
02/2005
1SincalideFDA Link
02/2005

Therapy/Procedure

6Therapeutics
01/2023 - 01/2006
2Precision Medicine
01/2022 - 01/2020
2Injections
12/2020 - 01/2006
1Immunotherapy
11/2021
1Radiotherapy
11/2021
1Combination Drug Therapy (Combination Chemotherapy)
12/2019
1Drug Therapy (Chemotherapy)
03/2011
1Aftercare (After-Treatment)
02/2005